Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Tordai A, Bors A, Kiss KP, Balassa K, Andrikovics H, Batai A, Szilvasi A, Rajczy K, Inotai D, Torbagyi E, Lengyel L, Barta A, Remenyi P, Masszi T. Tordai A, et al. Among authors: torbagyi e. PLoS One. 2019 Jun 25;14(6):e0218945. doi: 10.1371/journal.pone.0218945. eCollection 2019. PLoS One. 2019. PMID: 31237928 Free PMC article.
Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Balassa K, Krahling T, Remenyi P, Batai A, Bors A, Kiss KP, Torbagyi E, Gopcsa L, Lengyel L, Barta A, Varga G, Tordai A, Masszi T, Andrikovics H. Balassa K, et al. Among authors: torbagyi e. Leuk Lymphoma. 2017 Feb;58(2):391-398. doi: 10.1080/10428194.2016.1198956. Epub 2016 Jul 7. Leuk Lymphoma. 2017. PMID: 27389386
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.
Balassa K, Andrikovics H, Remenyi P, Batai A, Szilvasi A, Bors A, Kiss KP, Rajczy K, Inotai D, Torbagyi E, Lengyel L, Barta A, Gopcsa L, Tordai A, Masszi T. Balassa K, et al. Among authors: torbagyi e. Hum Immunol. 2018 Jan;79(1):13-19. doi: 10.1016/j.humimm.2017.10.010. Epub 2017 Oct 31. Hum Immunol. 2018. PMID: 29080718
[Allogeneic hematopoietic stem cell transplantation in Hungary].
Bátai Á, Reményi P, Réti M, Barta A, Gopcsa L, Lengyel L, Torbágyi É, Csukly Z, Karászi É, Tordai A, Andrikovics H, Balassa K, Tasnády S, Masszi T. Bátai Á, et al. Among authors: torbagyi e. Orv Hetil. 2017 Feb;158(8):291-297. doi: 10.1556/650.2017.30648. Orv Hetil. 2017. PMID: 28218567 Hungarian.
Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.
Reményi P, Gopcsa L, Marton I, Réti M, Mikala G, Pető M, Barta A, Bátai A, Farkas Z, Borbényi Z, Csukly Z, Bodó I, Fábián J, Király A, Lengyel L, Piukovics K, Torbágyi E, Masszi T. Reményi P, et al. Among authors: torbagyi e. Adv Ther. 2014 Apr;31(4):451-60. doi: 10.1007/s12325-014-0114-z. Epub 2014 Apr 1. Adv Ther. 2014. PMID: 24687301
Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemia.
Barta A, Dénes R, Masszi T, Reményi P, Bátai A, Torbágyi E, Sipos A, Lengyel L, Jakab K, Gyódi E, Réti M, Földi J, Páldi-Haris P, Avalos M, Pálóczi K, Fekete S, Török J, Hoffer I, Jakab J, Váradi G, Kelemen E, Petrányi G. Barta A, et al. Among authors: torbagyi e. Acta Haematol. 2001;105(2):64-70. doi: 10.1159/000046536. Acta Haematol. 2001. PMID: 11408706 Clinical Trial.
Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years.
Remenyi P, Varga G, Mikala G, Reti M, Gopcsa L, Batai A, Csukly Z, Lengyel L, Torbagyi E, Barta A, Fabian J, Levai D, Szombath G, Andrikovics H, Masszi T. Remenyi P, et al. Among authors: torbagyi e. Transplant Proc. 2016 Jan-Feb;48(1):177-84. doi: 10.1016/j.transproceed.2015.12.031. Transplant Proc. 2016. PMID: 26915865
Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state.
Barta A, Bátai A, Kelemen E, Lengyel L, Reményi P, Sipos A, Torbágyi E, Avalos M, Fekete E, Földi J, Páldi-Haris P, Tamáska J, Gyódi E, Rajczy K, Hoffer I, Jakab J, Petrányi GG, Pálóczi K. Barta A, et al. Among authors: torbagyi e. Hum Immunol. 2000 Feb;61(2):101-10. doi: 10.1016/s0198-8859(99)00143-3. Hum Immunol. 2000. PMID: 10717801 Review.
13 results